Cannabigerol and cannabichromene in Cannabis sativa L.
In addition to delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), other phytocannabinoids, such as cannabigerol (CBG) and cannabichromene (CBC), also have beneficial effects on human health. A high content of CBG is found in plants with the B0 genotype, whereas CBC is independent of the allel...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2021-09-01
|
| Series: | Acta Pharmaceutica |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/acph-2021-0021 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832570290347966464 |
|---|---|
| author | Zagožen Marjeta Čerenak Andreja Kreft Samo |
| author_facet | Zagožen Marjeta Čerenak Andreja Kreft Samo |
| author_sort | Zagožen Marjeta |
| collection | DOAJ |
| description | In addition to delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), other phytocannabinoids, such as cannabigerol (CBG) and cannabichromene (CBC), also have beneficial effects on human health. A high content of CBG is found in plants with the B0 genotype, whereas CBC is independent of the allelic chemotype locus B. In basic research models such as mice or rats, CBG has demonstrated anticancer properties, particularly against breast cancer. CBG has shown anti-inflammatory effects on murine colitis and on inflammatory bowel disease as well as stimulatory effects on the feeding behaviors of mice. It has also exhibited inhibition of aldose reductase, which is known to cause an accumulation of sorbitol and increase glucose levels in the blood, which may lead to diabetes. Cannabinoid CBC has also shown anti-inflammatory effects and reduced hypermobility in the gut and has displayed potential in vitro effect on adult neural stem progenitor cells. CBC also exerts modest analgesic properties in rodents, as well as anti-fungal, anti-bacterial, pro-apoptotic, and anti-proliferative effects in tumor cells. |
| format | Article |
| id | doaj-art-22ad8fc283964ab68ac03b49617694a7 |
| institution | Kabale University |
| issn | 1846-9558 |
| language | English |
| publishDate | 2021-09-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Acta Pharmaceutica |
| spelling | doaj-art-22ad8fc283964ab68ac03b49617694a72025-02-02T15:49:11ZengSciendoActa Pharmaceutica1846-95582021-09-0171335536410.2478/acph-2021-0021acph-2021-0021Cannabigerol and cannabichromene in Cannabis sativa L.Zagožen Marjeta0Čerenak Andreja1Kreft Samo2Department for Plants, Soil, and Environment, Slovenian Institute of Hop Research and Brewing, 3310 ZalecSloveniaDepartment for Plants, Soil, and Environment, Slovenian Institute of Hop Research and Brewing, 3310 ZalecSloveniaThe Chair of Pharmaceutical Biology University of Ljubljana, Faculty of Pharmacy, Ljubljana, SloveniaIn addition to delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), other phytocannabinoids, such as cannabigerol (CBG) and cannabichromene (CBC), also have beneficial effects on human health. A high content of CBG is found in plants with the B0 genotype, whereas CBC is independent of the allelic chemotype locus B. In basic research models such as mice or rats, CBG has demonstrated anticancer properties, particularly against breast cancer. CBG has shown anti-inflammatory effects on murine colitis and on inflammatory bowel disease as well as stimulatory effects on the feeding behaviors of mice. It has also exhibited inhibition of aldose reductase, which is known to cause an accumulation of sorbitol and increase glucose levels in the blood, which may lead to diabetes. Cannabinoid CBC has also shown anti-inflammatory effects and reduced hypermobility in the gut and has displayed potential in vitro effect on adult neural stem progenitor cells. CBC also exerts modest analgesic properties in rodents, as well as anti-fungal, anti-bacterial, pro-apoptotic, and anti-proliferative effects in tumor cells.https://doi.org/10.2478/acph-2021-0021cannabinoidschemotypehealth effectshempreceptors |
| spellingShingle | Zagožen Marjeta Čerenak Andreja Kreft Samo Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharmaceutica cannabinoids chemotype health effects hemp receptors |
| title | Cannabigerol and cannabichromene in Cannabis sativa L. |
| title_full | Cannabigerol and cannabichromene in Cannabis sativa L. |
| title_fullStr | Cannabigerol and cannabichromene in Cannabis sativa L. |
| title_full_unstemmed | Cannabigerol and cannabichromene in Cannabis sativa L. |
| title_short | Cannabigerol and cannabichromene in Cannabis sativa L. |
| title_sort | cannabigerol and cannabichromene in cannabis sativa l |
| topic | cannabinoids chemotype health effects hemp receptors |
| url | https://doi.org/10.2478/acph-2021-0021 |
| work_keys_str_mv | AT zagozenmarjeta cannabigerolandcannabichromeneincannabissatival AT cerenakandreja cannabigerolandcannabichromeneincannabissatival AT kreftsamo cannabigerolandcannabichromeneincannabissatival |